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Summary
Background: After extensive encircling of ipsilateral pulmonary vein isolation (EEPVI) for atrial
ﬁbrillation (AF), we sometimes observe AF recurrence, or the occurrence of atrial tachycardia
originating from the left atrium. This study examined the efﬁcacy of additional linear ablation
at the left atrial (LA) roof in combination with EEPVI to prevent arrhythmia recurrences.
Methods: This study included 104 patients with drug-refractory AF (75 with paroxysmal, 29 with
persistent). The patients in Group A (n = 70) underwent EEPVI treatment alone, and the patients
in Group B (n = 34) underwent linear ablation at the LA roof in addition to EEPVI treatment. At
1, 3, 6, and 12 months after ablation, patients underwent clinical review and 24-h ambulatory
electrocardiogram monitoring to identify asymptomatic arrhythmias. Follow-up included daily
trans-telephonic event monitoring, transmitted irrespective of the patient’s symptoms.
Results: At 12 months, 57% of Group A and 79% of Group B were free of arrhythmias (p < 0.05).
Cox regression analysis demonstrated that among the variables of age, sex, duration of AF,
types of AF (paroxysmal or persistent), LA size, ejection fraction, existence of hypertension,
ischemic heart disease, valvular heart disease, history of stroke, and the ablation technique,
only the ablation technique of the linear block at the LA roof was the independent predictor of
arrhythmia-free recovery after ablation.
Conclusions: EEPVI in combination with the linear ablation at the LA roof is associated with an
comp
f Carimproved clinical outcome
© 2010 Japanese College o∗ Corresponding author. Tel.: +81 59 231 5466;
ax: +81 59 231 5466.
E-mail address: fujii-e@clin.medic.mie-u.ac.jp (E. Fujii).
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diology. Published by Elsevier Ireland Ltd. All rights reserved.
ntroductionxtensive encircling of ipsilateral pulmonary vein (PV)
solation (EEPVI) has been reported to be an effective
reatment for paroxysmal atrial ﬁbrillation (AF), resulting
n a success rate between 85% and 88% [1—3]. However,
Published by Elsevier Ireland Ltd. All rights reserved.
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the success rate of EEPVI for persistent AF is between
38% and 68%, and it is obviously low compared with that
for paroxysmal AF [2,3]. Moreover, left atrial (LA) ﬂut-
ter or macroreentrant atrial tachycardia (AT) might be
newly generated after circumferential PV isolation [4,5].
Although the efﬁcacy of complete linear block at the LA
roof for paroxysmal AF has already been demonstrated to
prevent recurrent arrhythmias [6], no studies have demon-
strated the efﬁcacy of linear block at the LA roof for
all types of AF. The aim of this study was to examine
the efﬁcacy of linear ablation at the LA roof in com-
bination with EEPVI to prevent AT occurrence and AF
recurrences in medically refractory, paroxysmal and persis-
tent AF patients.
Methods
Study population
We retrospectively studied 104 patients who underwent
radiofrequency catheter ablation for drug-refractory AF at
a single institution. From January 2005 to August 2006 and
from January 2008 to August 2008, 70 patients received
EEPVI treatment alone (Group A), and from September
2006 to December 2007, 34 patients received linear abla-
tion at the LA roof in addition to EEPVI treatment (Group
B). AF is classiﬁed as paroxysmal if episodes terminate
spontaneously in less than 7 days, and as persistent if
there is a failure to self-terminate within 7 days. Long-
standing persistent AF was deﬁned as AF lasting for more
than 1 year. There were 75 patients with paroxysmal
and 29 patients with persistent (including 14 with long-
standing) AF. After institutional review board approval,
medical records were reviewed for past cardiac medical
history.
Electrophysiological study
After informed written consent was obtained, an electro-
physiological study was performed in the postabsorptive
state under light sedation [7]. All antiarrhythmic agents
had been discontinued for 3 days. All patients had effec-
tive anticoagulation for >2 months, and transesophageal
echocardiography was performed to exclude the possibility
of LA thrombus just before ablation. Oral anticoagula-
tion was replaced by drip infusion of heparin >48 h before
ablation, and heparin ceased 6 h before the procedure.
After internal jugular and femoral vein punctures were
performed, a heparin bolus (100U/kg) was administered
and afterward, continuous infusion of heparin was pro-
vided, maintaining an activated clotting time value between
250 and 300 s. Surface electrocardiogram (ECG) and bipo-
lar endocardial electrograms were continuously monitored
and stored on a computer-based digital ampliﬁer/recorder
system for ofﬂine analysis (Bard Electrophysiology, Low-
ell, MA, USA). Intracardiac electrograms were ﬁltered
from 30 to 500Hz and measured at a sweep speed of
100mm/s.
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xtensive encircling of ipsilateral pulmonary vein
solation and rooﬂine ablation
he following catheters were introduced via the right
emoral vein and right internal jugular vein for elec-
rophysiological evaluation and ablation: (1) a 20-pole
atheter (Woven Diagnostic Electrode Catheter; Bard Elec-
rophysiology) was positioned in the coronary sinus; (2) a
ircumferential 20-pole catheter (Lasso; Biosense-Webster,
iamond Bar, CA, USA) was introduced into the PV after
ransseptal access with the use of a long sheath (Mullins
F transseptal Catheter Introducer Set; Medtronic, Santa
osa, CA, USA and Swartz SR0; St Jude Medical, St Paul,
N, USA); and (3) a 4-mm tip ablation catheter (Navistar;
iosense-Webster) was used for mapping and ablation. Map-
ing was performed during coronary sinus pacing and sinus
hythm. In the case of AF, sinus rhythm was restored by
xternal cardioversion. After LA reconstruction, each PV
stium was identiﬁed by selective venography and tagged on
he electroanatomical map. Two circumferential catheters
ere placed within the ipsilateral superior and inferior PVs
r within the superior and inferior branches of a common
V trunk to record PV potentials [8]. Radiofrequency energy
as delivered with a target temperature of 55 ◦C, at a maxi-
al power limit of 30W. Radiofrequency ablation sites were
agged on the reconstructed 3D-LA. Radiofrequency energy
as applied for 30 s until the maximal local electrogram
mplitude decreased by >70% or double potentials were
oted. Radiofrequency ablation was performed when the
osterior wall was more than 1 cm and the anterior wall
ore than 5mm from the angiographically deﬁned PV ostia.
he end point of the PV isolation was deﬁned by complete
limination or dissociation of PV potentials determined with
he circumferential catheter [8].
After EEPVI, LA roof ablation was performed by the cre-
tion of a contiguous line of ablation lesions joining the
uperior PVs in Group B [6]. LA roof ablation was performed
n all cases in a temperature-controlled mode with temper-
ture limited to 55 ◦C. A delivered power of 30—35W was
sed. Radiofrequency energy was delivered for 30 s at each
oint. The electrophysiological end point for LA roof abla-
ion was by demonstration of a complete line of block joining
he two superior PVs.
ollow-up
ll patients were monitored in the hospital for at least 3
ays after their procedures. Patients with paroxysmal AF
ere followed without anti-arrhythmic drug administration
fter ablation, and patients with persistent AF received an
nti-arrhythmic drug within 3 months after ablation and
ere then followed without anti-arrhythmic drug. At 1, 3,
, and 12 months after ablation, patients underwent clini-
al review and 24-h ambulatory ECG monitoring to identify
symptomatic arrhythmias. Follow-up included daily trans-
elephonic event monitoring transmitted irrespective of the
atient’s symptoms [7].
Early AF recurrences (within 3 months after ablation)
ere not taken into account for data analysis, because
hese episodes are often a transient phenomenon reﬂecting
reverse remodeling process [9].
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Figure 1 Left and right upper panel: left anterior oblique and cranial view of three-dimensional left atrial geometry reconstructed
by the EnSite system. White tags indicate the ablation sites for the left atrial roof. Non-contact isochronal map during distal coronary
sinus pacing demonstrates the activation detour to the posterior left atrial wall. Lower panel: virtual 7—10 unipolar electrograms
were located on the rooﬂine. The electrogram shows the corridor of double potentials recorded at various sites on the line. Note
the activation delay is shorter to the second potential at the right pulmonary vein (128ms) compared with the left pulmonary
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Bein (149ms). BOB 1, 2, 3 EP Cath 1, 2, 3: distal, middle, pro
1: surface electrocardiographic leads I, aVF, V1; LAA: left atri
nnulus; RSPV: right superior pulmonary vein; virtual: non-cont
tatistical analysis
ll values are expressed as mean± SD. Comparisons
etween groups were performed with the Student t-test. A
aplan—Meier analysis with log-rank test was used to deter-
ine the probability of freedom from recurrent AF or AT. A
ultivariate Cox regression analysis was performed to deter-
ine the independent predictors of the recurrence of AF or
he occurrence of AT. Statistical signiﬁcance was established
t p < 0.05.
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Table 1 Baseline characteristics.
Group A (n = 70)
Age (years) 61± 10
Male (%) 59 (84)
Duration of AF (month) 82± 85
Number of antiarrhythmic drugs 3± 2
LA diameter (mm) 42± 6
LV ejection fraction (%) 63± 10
Paroxysmal AF/persistent AF 51/19
Hypertension (%) 39 (56)
Ischemic heart disease (%) 10 (14)
Valvular disease (%) 5 (7)
Cerebral infarction (%) 9 (13)
Chronic renal failure (%) 3 (4)
Continuous valuables are shown as mean± SD. AF: atrial ﬁbrillation; LAl coronary sinus electrogram; CS: coronary sinus; ECG I, aVF,
pendage; LSPV: left superior pulmonary vein; MA: mitral valve
nipolar electrogram.
esults
atient characteristics
aseline characteristics of patients are presented in Table 1.
o signiﬁcant difference was observed in age, gender, dura-
ion of AF, number of anti-arrhythmic drugs used before
blation, LA diameter, or left ventricular ejection fraction
etween the two groups. There were also no differences
Group B (n = 34) p-Value
57± 14 0.141
25 (74) 0.198
61± 58 0.204
3± 2 0.493
40± 7 0.130
63± 10 0.796
24/10 0.819
21 (61) 0.673
3 (9) 0.539
4 (12) 0.470
3 (9) 0.747
1 (3) 0.999
: left atrial; and LV: left ventricular.
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aFigure 2 Kaplan—Meier analysis for the absence of arrhyth-
mia during follow-up. AF: atrial ﬁbrillation and AT: atrial
tachycardia.
in structural heart disease, history of hypertension, cere-
bral infarction, or chronic renal failure between the two
groups.
Catheter ablation and clinical outcome
Every patient’s PVs in both groups were successfully electri-
cally isolated. In Group B, a line of conduction block of the
LA roof was successfully completed in all patients. For the
ﬁrst 5 patients of Group B, a multi-electrode array used with
the EnSite system (EnSite 3000 with Precision Software, End-
cardial Solutions, Inc., St Paul, MN, USA) was introduced into
the left atrium through a long sheath. Isochronal mapping
in the presence of conduction block during LA appendage
or distal coronary sinus pacing demonstrated more rapid
propagation of the activation front around the left PVs
than around the septum, resulting in a shorter conduction
time at the left than the right extremity of the line. This
resulted in activation delay shorter to the second poten-
tial at the right PV compared with the left PV (Fig. 1). For
the remaining patients of Group B, complete linear block
was deﬁned by demonstration by point-by-point mapping
of an online corridor of double potentials along the entire
length of the roof during pacing of the LA appendage [6].
The mean procedure duration was not signiﬁcantly differ-
ent in both groups (225± 37min vs. 237± 35min, p = 0.39).
Additional radiofrequency application for the LA roof did not
signiﬁcantly increase the ﬂuoroscopy time (79± 13min vs.
83± 12min, p = 0.39).
Freedom from recurrent AF or AT
Atmonth 12 of the follow-up period, excluding blanking peri-
ods, without antiarrhythmic drugs, 79% of the patients in
Group B were free of AF and AT, compared with 57% from
Group A (p < 0.01, log-rank test; Fig. 2). Second sessions for
the recurrent AF or AT developed after the ﬁrst ablation
procedure were not included in this study.
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redictors of outcome
mong the variables of age, sex, duration of AF, types of
F (paroxysmal or persistent), LA size, ejection fraction,
xistence of hypertension, ischemic heart disease, valvular
eart disease, history of stroke, and the ablation technique,
nly the ablation technique of EEPVI in combination with
inear block at the LA roof was the independent predictor
f arrhythmia free recovery after radiofrequency catheter
blation (p < 0.05; Table 2).
omplications
he procedure was complicated in 1 patient by pericardial
amponade during left PV isolation. Percutaneous drainage
as performed with no long-term consequence.
iscussion
n this study, the linear ablation of the LA roof in addition to
EPVI was associated with 79% of patients being arrhythmia
ree compared with 57% undergoing EEPVI alone, for patients
ith not only paroxysmal AF, but also persistent AF.
EEPVI can eliminate the triggering foci inside and outside
Vs [8], produce autonomic denervation [10], and partially
lter the LA substrate necessary for perpetuating AF [11].
owever, left AT appears to be more common following cir-
umferential, as opposed to segmental, PV isolation [12,13].
ew reentrant circuits created by the ablation lesions can
ead to macroreentrant left AT [14]. Hocini et al. reported
hat PV isolation in combination with linear ablation join-
ng the two superior PVs was associated with an improved
linical outcome compared with PV isolation alone for parox-
smal AF [6]. The LA roof represents a region demonstrating
ighly fragmented electrograms, indicating the presence of
substrate required for maintaining AF [6,11]. The reen-
ry circuits tend to develop around regions of the LA scar,
nd often involve the LA roof between the two superior PVs.
lthough we could not examine the presence of a substrate
uch as continuous fragmented atrial electrograms required
or maintaining AF because EEPVI or linear ablation at the
A roof was performed during sinus rhythm in this study,
e demonstrated the efﬁcacy of linear ablation of the LA
oof in combination with EEPVI to prevent the occurrence of
rrhythmia after ablation for all types of AF patients. Due
o anatomic barriers, successful ablation to prevent AT after
EPVI may be performed by creating the line of block at the
A roof.
Although more extensive ablations, such as linear abla-
ion of the LA roof, mitral isthmus, and posterior LA,
r targeting complex fractionated electrograms [11], may
ecrease the rate of AF recurrence for persistent AF, linear
blation of the mitral isthmus requires long radiofrequency
nergy delivery and ablation distally within the coronary
inus, and atrio-esophageal ﬁstulas can occur after catheter
blation in the posterior wall of the LA [15]. According to
hese ﬁndings, linear ablation of the LA roof is a safe and
ffective procedure. Omichi et al. reported that treatment
ith catheter ablation for tachycardia-induced cardiomy-
pathy could reverse sympathetic neurological remodeling
s well as myocardial structural remodeling [16]. In this
326 M. Senga et al.
Table 2 Results of Cox regression in the 104 patients with paroxysmal and persistent AF.
Covariates ˇ Standard error p-Value Hazard ratio
Age 0.016 0.018 0.362 1.016
Sex −0.098 0.448 0.827 0.907
Duration of AF 0.001 0.002 0.565 1.001
Persistent AF −0.299 0.453 0.509 0.741
LA diameter 0.011 0.034 0.737 1.011
LV ejection fraction −1.162 1.703 0.495 0.313
Hypertension 0.179 0.381 0.638 1.196
Ischemic heart disease −0.577 0.575 0.316 0.562
Valvular disease 0.090 0.632 0.887 1.094
Cerebral infarction 0.069 0.553 0.901 1.071
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RLA roof ablation −0.890 0
AF: atrial ﬁbrillation; LA: left atrial; and LV: left ventricular.
tudy, anti-arrhythmic drugs had been continued for 3
onths after ablation for the patients with persistent AF.
e speculated that hybrid effect of ablation and anti-
rrhythmic drugs may reverse the atrial remodeling early
fter ablation procedure and that the maintenance of sinus
hythm may also reverse the atrial remodeling after dis-
ontinuation of anti-arrhythmic drugs in the patients with
ersistent AF.
linical implications
he present study suggests that EEPVI in combination with
A roof ablation results in suppressed AF recurrence and the
ccurrence of AT compared with EEPVI alone in patients with
ll types of AF.
imitations
his study is a single-center endeavor, and any conclusions
ust be regarded with appropriate circumspection. Another
ajor limitation is that this is a retrospective study that
eeds prospective conﬁrmation.
onclusion
he present study demonstrates that the linear ablation of
he LA roof in combination with EEPVI is associated with an
mproved clinical outcome compared with EEPVI alone.
eferences
[1] Hachiya H, Hirao K, Takahashi K, Nagata Y, Suzuki K, Maeda
S, Sasaki T, Kawabata M, Isobe M, Iesaka Y. Clinical implica-
tions of reconnection between the left atrium and isolated
pulmonary veins provoked by adenosine triphosphate after
extensive encircling pulmonary vein isolation. J Cardiovasc
Electrophysiol 2007;18:399—401.[2] Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M,
Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P,
Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V,
et al. Atrial electroanatomic remodeling after circumferen-
tial radiofrequency pulmonary vein ablation: efﬁcacy of an
[0.044 0.411
anatomic approach in a large cohort of patients with atrial
ﬁbrillation. Circulation 2001;104:2539—44.
[3] Kottkamp H, Tanner H, Kobza R, Schirdewahn P, Dorszewski
A, Gerds-Li JH, Carbucicchio C, Piorkowski C, Hindricks G.
Time courses and quantitative analysis of atrial ﬁbrillation
episode number and duration after circular plus linear left
atrial lesions—–trigger elimination or substrate modiﬁcation:
early or delayed cure? J Am Coll Cardiol 2004;44:869—
77.
[4] Deisenhofer I, Estner H, Zrenner B, Schreieck J, Weyerbrock
S, Hessling G, Scharf K, Karch MR, Schmitt C. Left atrial
tachycardia after circumferential pulmonary vein ablation
for atrial ﬁbrillation: incidence, electrophysiological charac-
teristics, and results of radiofrequency ablation. Europace
2006;8:573—82.
[5] Mesas CE, Pappone C, Lang CCE, Gugliotta F, Tomita T, Vice-
domini G, Sala S, Paglino G, Gulletta S, Ferro A, Santinelli V.
Left atrial tachycardia after circumferential pulmonary vein
ablation for atrial ﬁbrillation: electroanatomic characteriza-
tion and treatment. J Am Coll Cardiol 2004;44:1071—9.
[6] Hocini M, Jais P, Sanders P, Takahashi Y, Rotter M, Rostock T, Hsu
LF, Sacher F, Reuter S, Clementy J, Haissaguerre M. Techniques,
evaluation, and consequences of linear block at the left atrial
roof in paroxysmal atrial ﬁbrillation—–a prospective randomized
study. Circulation 2005;112:3688—96.
[7] Senga M, Fujii E, Sugiura S, Yamazato S, Nakamura M, Ito M.
The utility of transtelephonic electrocardiograms for detecting
arrhythmia recurrences after radiofrequency catheter ablation
for atrial ﬁbrillation. J Arrhythmia 2009;25:130—4.
[8] Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen
M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH. Complete
isolation of left atrium surrounding the pulmonary veins: new
insights from the double-Lasso technique in paroxysmal atrial
ﬁbrillation. Circulation 2004;110:2090—6.
[9] European Heart Rhythm Association (EHRA), European Cardiac
Arrhythmia Society (ECAS), American College of Cardiology
(ACC), American Heart Association (AHA), Society of Thoracic
Surgeons (STS), Calkins H, Brugada J, Packer DL, Cappato R,
Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE,
Haissaguerre M, et al. HRS/EHRA/ECAS expert consensus state-
ment on catheter and surgical ablation of atrial ﬁbrillation:
recommendations for personnel, policy, procedures and follow-
up. A report of the Heart Rhythm Society (HRS) Task Force
on catheter and surgical ablation of atrial ﬁbrillation. Heart
Rhythm 2007;4:816—61.
10] Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta
F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A,
Dicandia C, Rosanio S. Pulmonary vein denervation enhances
tion
[
[Efﬁcacy of linear block at the left atrial roof in atrial ﬁbrilla
long-term beneﬁt after circumferential ablation for paroxys-
mal atrial ﬁbrillation. Circulation 2004;109:327—34.
[11] Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsanee-
witayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. A new
approach for catheter ablation of atrial ﬁbrillation: map-
ping of the electrophysiologic substrate. J Am Coll Cardiol
2004;43:2044—53.
[12] Karch M, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G,
Dong J, Lamprecht K, Barthel P, Luciani E, Schomig A, Schmitt
C. Freedom from atrial tachyarrhythmias after catheter abla-
tion of atrial ﬁbrillation: a randomized comparison between
2 current ablation strategies. Circulation 2005;111:2875—
80.
[13] Kanagaratnam L, Tomassoni G, Schweikert R, Pavia S, Bash
D, Beheiry S, Lesh M, Niebauer M, Saliba W, Chung M, Tchou
P, Natale A. Empirical pulmonary vein isolation in patients
with chronic atrial ﬁbrillation using a three-dimensional non-
[327
ﬂuoroscopic mapping system: long-term follow-up. Pacing Clin
Electrophysiol 2001;24:1774—9.
14] Haissaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M,
Sacher F, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut
R, Clementy J, Jais P. Catheter ablation of long-lasting per-
sistent atrial ﬁbrillation: critical structures for termination. J
Cardiovasc Electrophysiol 2005;16:1125—37.
15] Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Man-
guso F, Torracca L, Benussi S, Alﬁeri O, Hong R, Lau W, Hirata
K, Shikuma N, Hall B, Morady F. Atrio-esophageal ﬁstula as a
complication of percutaneous transcatheter ablation of atrial
ﬁbrillation. Circulation 2004;109:2724—6.16] Omichi C, Tanaka T, Kakizawa Y, Yamada A, Ishii Y, Nagashima
H, Kanmatsuse K, Endo M. Improvement of cardiac function
and neurological remodeling in a patient with tachycardia-
induced cardiomyopathy after catheter ablation. J Cardiol
2009;54:134—8.
